Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human MAGEA6 Protein, N-His

Catalog #:   YHE42101 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P43360
Protein length: Ser96-Glu314
Overview

Catalog No.

YHE42101

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser96-Glu314

Predicted molecular weight

27.19 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P43360

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

MAGEA6, Cancer/testis antigen 1.6, MAGE6, MAGE3B antigen, MAGE-6 antigen, CT1.6, Melanoma-associated antigen 6

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human MAGEA6 protein
References

Gene and Protein Expression of MAGE and Associated Immune Landscape Elements in Non-Small-Cell Lung Carcinoma and Urothelial Carcinomas., PMID:39169899

Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia., PMID:38378601

Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma., PMID:37866309

TGM2, HMGA2, FXYD3, and LGALS4 genes as biomarkers in acquired oxaliplatin resistance of human colorectal cancer: A systems biology approach., PMID:37535601

Body composition and lung cancer-associated cachexia in TRACERx., PMID:37045997

Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report., PMID:36750254

Molecular Characteristics of Bladder Tumor: Increased Gene Expression of MAGE-A6 and MAGE-A11 with Decreased MicroRNA-34a and MicroRNA-125b., PMID:36341564

Identification of hub genes in AR-induced tamoxifen resistance in breast cancer based on weighted gene co-expression network analysis., PMID:36334189

DDX17 promotes the growth and metastasis of lung adenocarcinoma., PMID:36273228

Chemical complementarity between tumor resident, T-cell receptor CDR3s and MAGEA3/6 correlates with increased melanoma survival: Potential relevance to MAGE vaccine auto-reactivity., PMID:35987136

Identification of a seven-gene signature predicting clinical outcome of liver cancer based on tumor mutational burden., PMID:35622212

Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients., PMID:35565356

Knockdown of MAGE-A6 enhanced the irradiation sensitivity of non-small cell lung cancer cells by activating the AMPK pathway., PMID:35285568

Differential gene expression and network analysis in head and neck squamous cell carcinoma., PMID:35142951

MAGEA6 positively regulates MSMO1 and promotes the migration and invasion of oesophageal cancer cells., PMID:35126707

Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer., PMID:35022469

Identification of Key Genes Associated with Progression and Prognosis of Bladder Cancer through Integrated Bioinformatics Analysis., PMID:34885040

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma., PMID:34676211

Multiomics Differences in Lung Squamous Cell Carcinoma Patients with High Radiosensitivity Index Compared with Those with Low Radiosensitivity Index., PMID:34504628

Transcriptional overlap links DNA hypomethylation with DNA hypermethylation at adjacent promoters in cancer., PMID:34462486

Potential biomarkers and lncRNA-mRNA regulatory networks in invasive growth hormone-secreting pituitary adenomas., PMID:33559847

The Arg/N-degron pathway targets transcription factors and regulates specific genes., PMID:33229537

A comprehensive analysis of the MAGE family as prognostic and diagnostic markers for hepatocellular carcinoma., PMID:32941982

Clinical significance of long non-coding RNA DUXAP8 and its protein coding genes in hepatocellular carcinoma., PMID:32922554

The roles of MAGEA6 variants in pancreatic cancer development and their potential impact on cancer immunotherapy., PMID:32809888

Differential expression of MAGEA6 toggles autophagy to promote pancreatic cancer progression., PMID:32270762

Identification of key genes and pathways in gastric signet ring cell carcinoma based on transcriptome analysis., PMID:32149050

Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling., PMID:31727877

Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer., PMID:31704814

Epigenetic Coactivation of MAGEA6 and CT-GABRA3 Defines Orientation of a Segmental Duplication in the Human X Chromosome., PMID:31593956

Investigation into the expression levels of MAGEA6 in esophageal squamous cell carcinoma and esophageal adenocarcinoma tissues., PMID:31410142

Regulation of MAGE-A3/6 by the CRL4-DCAF12 ubiquitin ligase and nutrient availability., PMID:31267705

microRNA-448 inhibits stemness maintenance and self-renewal of hepatocellular carcinoma stem cells through the MAGEA6-mediated AMPK signaling pathway., PMID:31232474

MAGE-A expression in oral and laryngeal leukoplakia predicts malignant transformation., PMID:30936424

miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling., PMID:30056111

Knockdown of MAGEA6 Activates AMP-Activated Protein Kinase (AMPK) Signaling to Inhibit Human Renal Cell Carcinoma Cells., PMID:29448247

MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer., PMID:29430849

RNAi-mediated knockdown of Parp1 does not improve the development of female cloned mouse embryos., PMID:29050247

MAGEA6 promotes human glioma cell survival via targeting AMPKα1., PMID:29024810

Functional interaction between co-expressed MAGE-A proteins., PMID:28542476

Transcriptional profile of SH-SY5Y human neuroblastoma cells transfected by Toxoplasma rhoptry protein 16., PMID:27666388

The Magea gene cluster regulates male germ cell apoptosis without affecting the fertility in mice., PMID:27226137

Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy., PMID:27163739

Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma., PMID:26820613

Development of a Quantitative Real-Time RT-PCR Assay for the Detection of MAGE-A3-Positive Tumors., PMID:25986000

Oncogenic MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by ubiquitinating and degrading AMPK in cancer., PMID:25945414

MAGE-A expression clusters and antineoplastic treatment in head and neck cancer., PMID:25872923

Degradation of AMPK by a cancer-specific ubiquitin ligase., PMID:25679763

The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer., PMID:25653311

A Comprehensive Expression Analysis of Cancer Testis Antigens in Head and Neck Squamous Cell Carcinoma Revels MAGEA3/6 as a Marker for Recurrence., PMID:25564441

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human MAGEA6 Protein, N-His [YHE42101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only